Template:Rifampin isoniazid pyrazinamide: Difference between revisions

Jump to navigation Jump to search
mNo edit summary
mNo edit summary
Line 1: Line 1:
{| style="margin: 0 0 3em 3em; border: 1px solid #696969; float: right; width:20em" cellpadding="0" cellspacing="0";
{| style="margin: 0 0 3em 3em; border: 1px solid #696969; float: right; width:20em" cellpadding="0" cellspacing="0";
|-
|-
! style="padding: 0 5px; font-size: 100%; background:#F8F8FF" align=center | '''''[[Isoniazid|{{fontcolor|#6C7B8B|Isoniazid}}]]'''''
! style="padding: 0 5px; font-size: 100%; background:#F8F8FF" align=center | '''''[[Rifampin isoniazid pyrazinamide|{{fontcolor|#6C7B8B|Isoniazid}}]]'''''
|-
|-
! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left |RIFATER <sup>®</sup> FDA Package Insert
! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left |RIFATER <sup>®</sup> FDA Package Insert

Revision as of 14:25, 31 December 2013